Navigation Links
EPSScentral Responds to Pandemic Alert
Date:5/4/2009

ANNANDALE, Va., May 4 /PRNewswire/ -- EPSScentral LLC today announced its readiness to assist organizations in assembling, communicating, and implementing mitigation measures in the face of WHO's phase 5 classification of the Influenza A crisis. According to the WHO, phase 5 "...is a strong signal that a pandemic is imminent and that the time to finalize... mitigation measures is short."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080701/DC26612LOGO)

A world leader in ensuring organizational competency and performance, EPSScentral, together with pandemic content experts and technology partners, developed a package to address pandemic planning needs. Commencing with the SARS and Avian Flu crises over the past two years, EPSScentral developed the solution as a component of its process improvement and standard operating procedures practices. According to President and CEO Gary J. Dickelman, "It is socially responsible at this time to communicate our rapid, innovative approach to mitigating business disruption caused by Influenza A, especially in these challenging economic times. Having a solid plan in place mitigates overreacting to pandemic press. It prevents unnecessary business disruption while addressing the health and safety of employees in measured and responsible ways."

EPSScentral's offering includes: A baseline, easily customizable pandemic contingency plan; a set of templates and tools for rapid localization and deployment; resources to jump-start customization; and access to additional expert knowledge as the Influenza A (aka H1N1, Swine Flu) or other pandemic scenarios evolve. A sample EPSScentral pandemic plan can be viewed at http://pandemic.epssnews.com.

EPSScentral LLC is known for quality solutions that provide explicit, accessible and usable end-to-end best-practice processes; accelerate development and rollout by up to 80%; decrease time-to-competency; and foster remarkable returns on investment. Since 2002, the Company has provided thought leadership and mission critical solutions that transform business and assure the organizational mission at the speed of work. A hallmark is EPSScentral's ability to reduce organizational complexity as processes grow and supporting technologies evolve. Using EPSScentral's approach, their large private and public sector clients typically realize a ten-fold return on investment. Contact Shirah Cohen, VP, at scohen@epsscentral.net, 703-851-0545 and visit http://www.epsscentral.net.


'/>"/>
SOURCE EPSScentral LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
2. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
3. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
4. Roche responds to announcement of IDEAL hepatitis C trial results
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. USAID Cooperates in Pandemic Preparedness Initiative
7. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
8. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
10. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
(Date:6/23/2016)... 2016  Delcath Systems, Inc. (NASDAQ: DCTH ... on treatment of primary and metastatic liver cancers, announces ... - www.againsttheodds.eu - has been awarded a ... The website was developed as ... their families who are coping with the devastating diagnosis ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... ALKS ), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG ), ... BioTech Inc. (NASDAQ: ADRO ). Learn more about ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that ... dermaka cream can be incorporated into the post-surgical treatment plans of a variety of ... , dermaka cream is very effective for bruising and causes a rapid resolution of ...
Breaking Medicine News(10 mins):